Home Newsletters Pulmonary Cell News Coregulation of Pathways in Lung Cancer Patients with EGFR Mutation: Therapeutic Opportunities

Coregulation of Pathways in Lung Cancer Patients with EGFR Mutation: Therapeutic Opportunities

0
Scientists highlight regulatory mechanisms and signaling pathways that cause therapy-induced resistance to epidermal growth factor receptor tyrosine kinase inhibitors.
[British Journal of Cancer]

Sorry, but the selected Zotpress account can't be found.

Full Article
Exit mobile version